Benzinga | Nov 30, 2020 09:02AM EST

UPDATE: GeoVax Says License Agreement 'provides GeoVax with access to certain materials and patent rights owned by agencies of the Department of Health and Human Services' For Creation Of Ebola, Zika And Malaria, Among Others

The License Agreement provides GeoVax with access to certain materials and patent rights owned by agencies of the Department of Health and Human Services (HHS) for use in combination with the Company's proprietary technology for the creation of preventive and/or therapeutic vaccines against Ebola-Zaire, Ebola-Sudan, Lassa virus, Marburg virus, Zika virus and malaria. The agreement also extends to the Company's research and development efforts in certain oncology areas. The agreement provides GeoVax with nonexclusive rights for the nonclinical development and manufacturing of its vaccine and immunotherapy candidates using HHS patents and materials. Financial terms of the License Agreement were not disclosed.